Daniel L Hamilos
Overview
Explore the profile of Daniel L Hamilos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
3740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naclerio R, Hamilos D
J Allergy Clin Immunol Pract
. 2024 Apr;
12(4):1062-1064.
PMID: 38583923
No abstract available.
2.
Orlandi R, Kingdom T, Smith T, Bleier B, DeConde A, Luong A, et al.
Int Forum Allergy Rhinol
. 2020 Nov;
11(3):213-739.
PMID: 33236525
Executive Summary: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment...
3.
Faustino L, Griffith J, Rahimi R, Nepal K, Hamilos D, Cho J, et al.
Nat Immunol
. 2020 Sep;
21(11):1371-1383.
PMID: 32989331
Foxp3 regulatory T (T) cells expressing the interleukin (IL)-33 receptor ST2 mediate tissue repair in response to IL-33. Whether T cells also respond to the alarmin IL-33 to regulate specific...
4.
Cho S, Hamilos D, Han D, Laidlaw T
J Allergy Clin Immunol Pract
. 2020 May;
8(5):1505-1511.
PMID: 32389275
Chronic rhinosinusitis (CRS) is a complex heterogeneous disease with different phenotypes and endotypes. Recent advances in our understanding of the pathogenetic mechanisms of CRS endotypes have led to the introduction...
5.
Borish L, Hamilos D
J Allergy Clin Immunol Pract
. 2019 Nov;
7(8):2821-2822.
PMID: 31706495
No abstract available.
6.
Bachert C, Zinreich S, Hellings P, Mullol J, Hamilos D, Gevaert P, et al.
Rhinology
. 2019 Nov;
58(1):10-17.
PMID: 31671432
Background: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is associated with substantial sinus opacification. In a phase 2a study (NCT01920893), dupilumab, a fully human anti-IL-4Rα monoclonal antibody, improved outcomes in CRSwNP...
7.
Nazarian R, Lilly E, Gavino C, Hamilos D, Felsenstein D, Vinh D, et al.
J Cutan Pathol
. 2019 Aug;
47(2):166-170.
PMID: 31469433
Caspase Recruitment Domain Family Member 9 (CARD9) is an adaptor molecule that drives antifungal activity of macrophages and neutrophils in the skin. Autosomal recessive loss-of-function mutations in CARD9 confer increased...
8.
Bachert C, Hellings P, Mullol J, Hamilos D, Gevaert P, Naclerio R, et al.
Allergy
. 2019 Jul;
75(1):148-157.
PMID: 31306495
Background: Chronic rhinosinusitis with nasal polyposis (CRSwNP) negatively affects health-related quality of life (HRQoL). In a previously reported randomized clinical trial (NCT01920893), addition of dupilumab to mometasone furoate in patients...
9.
Adams D, Miller A, Applegate M, Cho J, Hamilos D, Chee A, et al.
Respirology
. 2019 Mar;
24(11):1073-1080.
PMID: 30845351
Background And Objective: In vivo evaluation of the microstructural differences between asthmatic and non-asthmatic airways and their functional consequences is relevant to understanding and, potentially, treating asthma. In this study,...
10.
Hamilos D
Curr Infect Dis Rep
. 2019 Mar;
21(2):8.
PMID: 30826880
Purpose Of Review: The purpose of this review is to discuss the unique pathways of biofilm formation utilized by respiratory pathogens and current and future therapeutic strategies to inhibit biofilm...